The startup has raised $10 million for antibody therapies for dogs and cats, but its CEO says animal health fundraising takes ...
The way we test new medicines in the U.S. is about to change. The FDA is officially moving away from animal testing and embracing new technologies that rely on human cells and artificial intelligence.
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results